digital health deals

Alongside a deeper collaboration with the not-for-profit system, Omada expects the funds to fuel expansion of its integrated digital care program.

The deal is expected to add 45,000 new Livongo members by 2021. 

Digital health's products are clashing with an established healthcare industry, and many stakeholders aren't sure the young companies are ready for its complexities.

The company has struck deals with VivaLNK and MIR, and is eying "more than 50 integrations by the end of next year."

Novartis has also announced that it will be opening a new AI innovation lab. 

Medisafe and its partner's joint program enrolled "thousands" of cardiometabolic patients and posted adherence increases greater those of the Medisafe app alone. 

The partners announced that they are putting out a request for clinical trial proposals in the areas of dermatology, gastroenterology, pulmonology, endocrinology, ophthalmology, inflammatory diseases, neurology, women’s health and rare diseases. 

The Belgium-based company's app can render heart rhythm irregularity readings in roughly 60 seconds.

Sanofi's deal with Abbott will be focusing on the diabetes space, while its deal with Happify will be looking at treating MS symptoms using a digital therapeutic. 

The pair will be targeting patients with asymptomatic or silent atrial fibrillation.